Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.15%
#3 Velvet Velvet +34.29%
#4 Black Phoenix Black Phoenix +34.09%
#5 Cross Cross +30.50%
#6 Akedo Akedo +28.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.95%
#8 QANplatform QANplatform +14.38%
#9 Perle Perle +13.09%
#10 Bitway Bitway +12.53%
Coin of the day
Glidr Glidr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
HAVN Life Sciences Inc. HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVN
Classement en actions #38702
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Prix de l'action
$0.02201811
Dernière synchronisation: 2024-07-23
Capitalisation boursière
$847.02K
Changement (1 jour)
-0.22%
Changement (1 an)
0.00%
Pays
CA
Échange HAVN Life Sciences Inc. (HAVN)

Catégorie

Healthcare
Ratio P/B pour HAVN Life Sciences Inc. (HAVN)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de HAVN Life Sciences Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour HAVN Life Sciences Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE